Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $41.24M in the quarter ending September 30, 2026, with 94.57% growth. This brings the company's total for the last twelve months to $137.43M, up 168.80% year-over-year. In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 644.94% growth. That makes Autolus Therapeutics the 20,295th largest company in the world by revenue and 3,096th in the United States.

• Revenue (ttm): $137.43M
• Revenue Growth: +168.80%
• P/S Ratio: 2.39
• Revenue / Employee: $182,273
• Employees: 754
• Market Cap: 326.05M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States of America 75.34M 99.9%
• Europe 50.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Autolus Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.39M	65.27M	644.94%
Dec 31, 2024	10.12M	8.42M	496.00%
Dec 31, 2023	1.70M	-4.68M	-73.38%
Dec 31, 2022	6.38M	4.87M	323.23%
Dec 31, 2021	1.51M	1.27M	522.73%
Dec 31, 2020	242.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Sep 30, 2018	-	-	-
Sep 30, 2017	-	-	-
Sep 30, 2016	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Nov 10, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error